Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Frontometaphyseal dysplasia 2

MONDO:0014935

Any frontometaphyseal dysplasia in which the cause of the disease is a mutation in the MAP3K7 gene.

Also known as: FMD2, Frontometaphyseal dysplasia 2, Frontometaphyseal dysplasia type 2, MAP3K7 frontometaphyseal dysplasia, frontometaphyseal dysplasia 2; FMD2, frontometaphyseal dysplasia caused by mutation in MAP3K7

2 clinical trials for this condition and its sub-types.

Follow this condition to get notified about new trials

Broader categories

Disease (717) Musculoskeletal system disorder (214) Hereditary disease (188) Bone disorder (51) Human disease (15) Skeletal system disorder (4) Disease of genetic or genomic mechanism (2) Frontometaphyseal dysplasia (2) Skeletal dysplasia (1) Disease by body system or component (0)
Not yet finished but already full! 1 Completed 1
Sort by
  • New hope for FSHD: Long-Term drug safety trial underway

    Disease control Ongoing

    This study is for people with FSHD, a genetic disease that causes muscle weakness. It tests the long-term safety and how well the body tolerates a drug called AOC 1020, given through a vein. About 84 adults who completed a previous study will take part. The main goal is to check …

    Phase 2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

    Last updated Jul 16, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space